{"reporting_entity_name": "John Hopkins Health Plans","reporting_entity_type": "Commercial","last_updated_on": "2026-09-22","version": "2.0","provider_references": [                                                                                                                                                                   
{"provider_group_id":4912316,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1003386780],"tin":{"type":"ein","value":"832558715","business_name":"POST ACUTE CARE CENTER"}}]},
{"provider_group_id":4912317,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1003552480],"tin":{"type":"ein","value":"881949601","business_name":"AUTUMN LAKE HEALTHCARE AT OAK MANOR"}}]},
{"provider_group_id":4912318,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1013593888],"tin":{"type":"ein","value":"861685288","business_name":"AUTUMN LAKE HEALTHCARE BRADFORD OAKS"}}]},
{"provider_group_id":4912319,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1013905579],"tin":{"type":"ein","value":"530196624","business_name":"THE VILLAGE AT ROCKVILLE"}}]},
{"provider_group_id":4912320,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1023871522],"tin":{"type":"ein","value":"934946348","business_name":"COPPER RIDGE NURSING AND ASSISTED LIVING CENTER"}}]},
{"provider_group_id":4912321,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1023893237],"tin":{"type":"ein","value":"923156740","business_name":"BETHESDA OPERATOR LLC"}}]},
{"provider_group_id":4912322,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1033264973],"tin":{"type":"ein","value":"520226260","business_name":"MARYLAND MASONIC HOMES LTD"}}]},
{"provider_group_id":4912323,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1033524186],"tin":{"type":"ein","value":"471116351","business_name":"FUTURECARE COURTLAND LLC"}}]},
{"provider_group_id":4912324,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1043214745],"tin":{"type":"ein","value":"521871748","business_name":"FUTURE CARE SANDTOWN"}}]},
{"provider_group_id":4912325,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1043870256],"tin":{"type":"ein","value":"834368112","business_name":"AUTUMN LAKE HEALTHCARE AT OAKVIEW"}}]},
{"provider_group_id":4912326,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1043896814],"tin":{"type":"ein","value":"861479910","business_name":"AUTUMN LAKE HEALTHCARE AT LONG GREEN"}}]},
{"provider_group_id":4912327,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1053609800,1710844447],"tin":{"type":"ein","value":"452632753","business_name":"NW SNF LLC"}}]},
{"provider_group_id":4912328,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1053771683],"tin":{"type":"ein","value":"811574300","business_name":"FUTURE CARE GOOD SAMARITAN"}}]},
{"provider_group_id":4912329,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1053843300],"tin":{"type":"ein","value":"371852149","business_name":"WINIFRED LEASING CO LLC"}}]},
{"provider_group_id":4912330,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1063699288],"tin":{"type":"ein","value":"261812072","business_name":"BEL PRE HEALTH AND REHAB CENTER"}}]},
{"provider_group_id":4912331,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1073199840],"tin":{"type":"ein","value":"861565885","business_name":"AUTUMN LAKE HEALTHCARE GLADE VALLEY"}}]},
{"provider_group_id":4912332,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1083173231],"tin":{"type":"ein","value":"833862135","business_name":"STERLING CARE RIVERSIDE"}}]},
{"provider_group_id":4912333,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1083891220],"tin":{"type":"ein","value":"261815994","business_name":"S RIVER HEALTH AND REHAB CENTER"}}]},
{"provider_group_id":4912334,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1114495728],"tin":{"type":"ein","value":"832407312","business_name":"COLLINGSWOOD REHAB AND HEALTHCARE CENTER"}}]},
{"provider_group_id":4912335,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1114632098],"tin":{"type":"ein","value":"921001720","business_name":"COMPLETE CARE AT HYATTSVILLE LLC"}}]},
{"provider_group_id":4912336,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1134120439],"tin":{"type":"ein","value":"660358677","business_name":"LORIEN NURSING AND REHAB COLUMBIA"}}]},
{"provider_group_id":4912337,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1134293137],"tin":{"type":"ein","value":"205836301","business_name":"KENSINGTON NURSING AND REHAB CENTER"}}]},
{"provider_group_id":4912338,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1134908478],"tin":{"type":"ein","value":"933154832","business_name":"TOWSON SNF OPERATIONS LLC"}}]},
{"provider_group_id":4912339,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1144806910],"tin":{"type":"ein","value":"861507248","business_name":"AUTUMN LAKE HEALTHCARE LOCH RAVEN"}}]},
{"provider_group_id":4912340,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1154029726],"tin":{"type":"ein","value":"922432421","business_name":"SLIGO CREEK HEALTHCARE"}}]},
{"provider_group_id":4912341,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1174527055],"tin":{"type":"ein","value":"520746920","business_name":"FUTURE CARE CHESAPEAKE"}}]},
{"provider_group_id":4912342,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1184312100],"tin":{"type":"ein","value":"923110904","business_name":"STERLING CARE HILLHAVEN"}}]},
{"provider_group_id":4912343,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1184373250],"tin":{"type":"ein","value":"881243395","business_name":"AUTUMN LAKE HEALTHCARE AT SUMMIT PARK"}}]},
{"provider_group_id":4912344,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1184620395],"tin":{"type":"ein","value":"521931794","business_name":"HOMEWOOD AT FREDERICK MD"}}]},
{"provider_group_id":4912345,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1194270256],"tin":{"type":"ein","value":"300924421","business_name":"DEVLIN MANOR NURSING AND REHABILITATION"}}]},
{"provider_group_id":4912346,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1194301861],"tin":{"type":"ein","value":"861432546","business_name":"AUTUMN LAKE HEALTHCARE AT SPA CREEK"}}]},
{"provider_group_id":4912347,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1194889246],"tin":{"type":"ein","value":"205896143","business_name":"LORIEN MAYS CHAPEL"}}]},
{"provider_group_id":4912348,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1245234939],"tin":{"type":"ein","value":"521379448","business_name":"FUTURE CARE PINEVIEW"}}]},
{"provider_group_id":4912349,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1265157564],"tin":{"type":"ein","value":"920552549","business_name":"HARTLEY NURSING AND REHAB LLC"}}]},
{"provider_group_id":4912350,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1265181317],"tin":{"type":"ein","value":"881083584","business_name":"AUTUMN LAKE HEALTHCARE AT ARCOL"}}]},
{"provider_group_id":4912351,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1265403703],"tin":{"type":"ein","value":"521710891","business_name":"PRIMARY CARE SVCS AT FAIRHAVEN"}}]},
{"provider_group_id":4912352,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1265433528],"tin":{"type":"ein","value":"043614792","business_name":"LORIEN BELAIR"}}]},
{"provider_group_id":4912353,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1275119042],"tin":{"type":"ein","value":"861604115","business_name":"AUTUMN LAKE HEALTHCARE AT PARKVILLE"}}]},
{"provider_group_id":4912354,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1275537995],"tin":{"type":"ein","value":"521949333","business_name":"FUTURE CARE HOMEWOOD"}}]},
{"provider_group_id":4912355,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1275827677],"tin":{"type":"ein","value":"451868035","business_name":"HARFORD ROAD HEALTH CARE LLC"}}]},
{"provider_group_id":4912356,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1285638908],"tin":{"type":"ein","value":"030493380","business_name":"FUTURE CARE IRVINGTON"}}]},
{"provider_group_id":4912357,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1295510402],"tin":{"type":"ein","value":"923155186","business_name":"MONTCARE AT POTOMAC"}}]},
{"provider_group_id":4912358,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1316946668],"tin":{"type":"ein","value":"530246852","business_name":"KNOLLWOOD"}}]},
{"provider_group_id":4912359,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1326336132],"tin":{"type":"ein","value":"452632434","business_name":"ANCHORAGE NURSING AND REHAB CENTER"}}]},
{"provider_group_id":4912360,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1356085245],"tin":{"type":"ein","value":"880888929","business_name":"FOREST HILL SNF OPERATOR LLC"}}]},
{"provider_group_id":4912361,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1366188740],"tin":{"type":"ein","value":"881977373","business_name":"AUTUMN LAKE HEALTHCARE AT CALVERT MANOR"}}]},
{"provider_group_id":4912362,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1366931206],"tin":{"type":"ein","value":"825202923","business_name":"SHADY GROVE NURSING AND REHAB CENTER"}}]},
{"provider_group_id":4912363,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1366997421],"tin":{"type":"ein","value":"371808833","business_name":"NORTHAMPTON MANOR NURSING AND REHAB CENTER"}}]},
{"provider_group_id":4912364,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1376075630],"tin":{"type":"ein","value":"611818918","business_name":"WASHINGTON W LEASING CO LLC"}}]},
{"provider_group_id":4912365,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1376889121],"tin":{"type":"ein","value":"455539003","business_name":"LORIEN BULLE ROCK HAVRE DE GRACE"}}]},
{"provider_group_id":4912366,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1386220143],"tin":{"type":"ein","value":"861714210","business_name":"AUTUMN LAKE HEALTHCARE AT BALLENGER CREEK"}}]},
{"provider_group_id":4912367,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1386632800],"tin":{"type":"ein","value":"030493387","business_name":"FUTURE CARE CHARLES VILLAGE"}}]},
{"provider_group_id":4912368,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1386821510],"tin":{"type":"ein","value":"261812291","business_name":"MARLEY NECK HEALTH AND REHAB CENTER"}}]},
{"provider_group_id":4912369,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1407561384],"tin":{"type":"ein","value":"884280663","business_name":"COMPLETE CARE AT HAGERSTOWN LLC"}}]},
{"provider_group_id":4912370,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1437162526],"tin":{"type":"ein","value":"521127007","business_name":"CARROLL LUTHERAN VILLAGE INC"}}]},
{"provider_group_id":4912371,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1437223427],"tin":{"type":"ein","value":"205836240","business_name":"CLINTON NURSING AND REHAB"}}]},
{"provider_group_id":4912372,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1437693785],"tin":{"type":"ein","value":"813903663","business_name":"KING DAVID AT AUTUMN LAKE LLC"}}]},
{"provider_group_id":4912373,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1457051344],"tin":{"type":"ein","value":"922775402","business_name":"AUTUMN LAKE HEALTHCARE AT TOWSON"}}]},
{"provider_group_id":4912374,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1477202547],"tin":{"type":"ein","value":"881067694","business_name":"AUTUMN LAKE HEALTHCARE AT PATUXENT RIVER"}}]},
{"provider_group_id":4912375,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1477546257],"tin":{"type":"ein","value":"202691094","business_name":"FUTURE CARE LOCHEARN"}}]},
{"provider_group_id":4912376,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1487962536],"tin":{"type":"ein","value":"273286015","business_name":"FAIRLAND CENTER"}}]},
{"provider_group_id":4912377,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1497292858],"tin":{"type":"ein","value":"520607956","business_name":"ASBURY SOLOMONS"}}]},
{"provider_group_id":4912378,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1497331268],"tin":{"type":"ein","value":"861468020","business_name":"AUTUMN LAKE HEALTHCARE AT PERRING PARKWAY"}}]},
{"provider_group_id":4912379,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1497741524],"tin":{"type":"ein","value":"260107427","business_name":"BRINTON WOODS OF WINFIELD"}}]},
{"provider_group_id":4912380,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1508311663],"tin":{"type":"ein","value":"364832305","business_name":"VILLA ROSA NURSING AND REHAB"}}]},
{"provider_group_id":4912381,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1508316126],"tin":{"type":"ein","value":"611788038","business_name":"FOREST HAVEN NURSING HOME CENTER"}}]},
{"provider_group_id":4912382,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1518226810],"tin":{"type":"ein","value":"371690544","business_name":"LOFLAND PARK CENTER"}}]},
{"provider_group_id":4912383,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1528847860],"tin":{"type":"ein","value":"933155224","business_name":"ROSSVILLE SNF OPERATIONS LLC"}}]},
{"provider_group_id":4912384,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1538736566],"tin":{"type":"ein","value":"871078756","business_name":"AUTUMN LAKE HEALTHCARE AT CROFTON"}}]},
{"provider_group_id":4912385,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1538905476],"tin":{"type":"ein","value":"993723263","business_name":"SNOW HILL REHAB AND HEALTHCARE CENTER"}}]},
{"provider_group_id":4912386,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1548261803],"tin":{"type":"ein","value":"522155375","business_name":"LORIEN LIFE CENTER-MT AIRY"}}]},
{"provider_group_id":4912387,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1558318386],"tin":{"type":"ein","value":"521734591","business_name":"FRANKLIN WOODS"}}]},
{"provider_group_id":4912388,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1558921759],"tin":{"type":"ein","value":"834380266","business_name":"AUTUMN LAKE HEALTHCARE AT RIVERVIEW"}}]},
{"provider_group_id":4912389,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1588313647],"tin":{"type":"ein","value":"881160158","business_name":"AUTUMN LAKE HEALTHCARE AT BALTIMORE WASHINGTON"}}]},
{"provider_group_id":4912390,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1598563561],"tin":{"type":"ein","value":"993170151","business_name":"FROSTBURG VILLAGE REHAB CENTER"}}]},
{"provider_group_id":4912391,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1609058171],"tin":{"type":"ein","value":"260816065","business_name":"HAMMONDS LANE CENTER"}}]},
{"provider_group_id":4912392,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1609859107],"tin":{"type":"ein","value":"521056690","business_name":"BROADMEAD INC"}}]},
{"provider_group_id":4912393,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1619682507],"tin":{"type":"ein","value":"921010529","business_name":"COMPLETE CARE AT SPRINGBROOK LLC"}}]},
{"provider_group_id":4912394,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1629072327],"tin":{"type":"ein","value":"522007563","business_name":"FUTURE CARE CANTON HARBOR"}}]},
{"provider_group_id":4912395,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1629572508],"tin":{"type":"ein","value":"824470397","business_name":"CHERRY LANE NURSING AND REHAB CENTER"}}]},
{"provider_group_id":4912396,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1629654496],"tin":{"type":"ein","value":"861625125","business_name":"AUTUMN LAKE HEALTHCARE AT CHESAPEAKE WOODS"}}]},
{"provider_group_id":4912397,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1639353816],"tin":{"type":"ein","value":"260798930","business_name":"ANSTED CENTER"}}]},
{"provider_group_id":4912398,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1639649312],"tin":{"type":"ein","value":"832558614","business_name":"ARLINGTON W CARE CENTER"}}]},
{"provider_group_id":4912399,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1649059973],"tin":{"type":"ein","value":"933155077","business_name":"ROLAND PARK SNF OPERATIONS LLC"}}]},
{"provider_group_id":4912400,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1649725797],"tin":{"type":"ein","value":"300925885","business_name":"FAIRFIELD NURSING AND REHAB CENTER"}}]},
{"provider_group_id":4912401,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1659904738],"tin":{"type":"ein","value":"843893522","business_name":"ALDELPHI NURSING REHAB CENTER LLC"}}]},
{"provider_group_id":4912402,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1669118980],"tin":{"type":"ein","value":"882002637","business_name":"AUTUMN LAKE HEALTHCARE AT BIRCH MANOR"}}]},
{"provider_group_id":4912403,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1669659884],"tin":{"type":"ein","value":"261812456","business_name":"FORT WASHINGTON HEALTH AND REHAB CENTER"}}]},
{"provider_group_id":4912404,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1679750897],"tin":{"type":"ein","value":"261812645","business_name":"FORESTVILLE HEALTH AND REHAB CENTER"}}]},
{"provider_group_id":4912405,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1699779470],"tin":{"type":"ein","value":"521614746","business_name":"FUTURE CARE CHERRYWOOD"}}]},
{"provider_group_id":4912406,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1700313798],"tin":{"type":"ein","value":"821408707","business_name":"THE NURSING AND REHAB CENTER AT STADIUM PLACE"}}]},
{"provider_group_id":4912407,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1720494313],"tin":{"type":"ein","value":"471244407","business_name":"AUTUMN LAKE HEALTHCARE AT ALICE MANOR"}}]},
{"provider_group_id":4912408,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1720686850],"tin":{"type":"ein","value":"852638625","business_name":"ROCKVILLE SNF OPERATOR LLC"}}]},
{"provider_group_id":4912409,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1740563931],"tin":{"type":"ein","value":"261331890","business_name":"LORIEN ELKRIDGE"}}]},
{"provider_group_id":4912410,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1740759463],"tin":{"type":"ein","value":"832327425","business_name":"CRESCENT CITIES NURSING AND REHAB CENTER"}}]},
{"provider_group_id":4912411,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1740981281],"tin":{"type":"ein","value":"922844478","business_name":"ADVANCE REHAB AT AUTUMN LAKE HEALTHCARE"}}]},
{"provider_group_id":4912412,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1750025649],"tin":{"type":"ein","value":"880912996","business_name":"STERLING CARE BETHESDA"}}]},
{"provider_group_id":4912413,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1750189627],"tin":{"type":"ein","value":"993170342","business_name":"S MOUNTAIN REHAB CENTER"}}]},
{"provider_group_id":4912414,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1750595518],"tin":{"type":"ein","value":"520634722","business_name":"WILLIAMSPORT NURSING HOME"}}]},
{"provider_group_id":4912415,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1760598155],"tin":{"type":"ein","value":"043187158","business_name":"LARKING CHASE NURSING CENTER"}}]},
{"provider_group_id":4912416,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1770038838],"tin":{"type":"ein","value":"320489150","business_name":"MORAN NURSING AND REHAB CENTER"}}]},
{"provider_group_id":4912417,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1770234817],"tin":{"type":"ein","value":"874159197","business_name":"TUCKERMAN REHAB AND HEALTHCARE CENTER"}}]},
{"provider_group_id":4912418,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1770283665],"tin":{"type":"ein","value":"922718717","business_name":"AUTUMN LAKE HEALTHCARE AT CHEVY CHASE"}}]},
{"provider_group_id":4912419,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1770810004],"tin":{"type":"ein","value":"208561046","business_name":"ENCORE AT TURF VALLEY"}}]},
{"provider_group_id":4912420,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1780139816],"tin":{"type":"ein","value":"364832324","business_name":"ALLEGANY HEALTH NURSING"}}]},
{"provider_group_id":4912421,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1780399667],"tin":{"type":"ein","value":"884280635","business_name":"COMPLETE CARE AT ANNAPOLIS LLC"}}]},
{"provider_group_id":4912422,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1790967446],"tin":{"type":"ein","value":"260789419","business_name":"MILFORD CENTER"}}]},
{"provider_group_id":4912423,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1821218066],"tin":{"type":"ein","value":"520591485","business_name":"KESWICK MULTI CARE CENTER INC"}}]},
{"provider_group_id":4912424,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1831190271],"tin":{"type":"ein","value":"201011187","business_name":"LORIEN NURSING AND REHAB CENTER"}}]},
{"provider_group_id":4912425,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1831667443],"tin":{"type":"ein","value":"832407100","business_name":"POTOMAC VALLEY REHAB AND HEALTHCARE CENTE"}}]},
{"provider_group_id":4912426,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1831696509],"tin":{"type":"ein","value":"824795614","business_name":"AUTUMN LAKE HEALTHCARE AT BRIDGEPARK"}}]},
{"provider_group_id":4912427,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1851578082],"tin":{"type":"ein","value":"261812212","business_name":"FAYETTE HEALTH AND REHAB CENTER"}}]},
{"provider_group_id":4912428,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1861141913],"tin":{"type":"ein","value":"881142291","business_name":"AUTUMN LAKE HEALTHCARE AT GLEN BURNIE"}}]},
{"provider_group_id":4912429,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1861673428],"tin":{"type":"ein","value":"260814286","business_name":"WALDORF CENTER"}}]},
{"provider_group_id":4912430,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1861851321],"tin":{"type":"ein","value":"320154392","business_name":"THE LUTHERAN VILLAGE AT MILLERS GRANT"}}]},
{"provider_group_id":4912431,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1871339507],"tin":{"type":"ein","value":"993194010","business_name":"RIDGEWAY REHAB LLC"}}]},
{"provider_group_id":4912432,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1891737573],"tin":{"type":"ein","value":"521961563","business_name":"DOCTORS COMM REHAB AND PATIENT CARE CENTER"}}]},
{"provider_group_id":4912433,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1912583683],"tin":{"type":"ein","value":"861394044","business_name":"AUTUMN LAKE HEALTHCARE WAUGH CHAPEL"}}]},
{"provider_group_id":4912434,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1912612896],"tin":{"type":"ein","value":"921010557","business_name":"COMPLETE CARE AT WHEATON LLC"}}]},
{"provider_group_id":4912435,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1922454891],"tin":{"type":"ein","value":"811955481","business_name":"FUTURECARE OLD COURT"}}]},
{"provider_group_id":4912436,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1922708726],"tin":{"type":"ein","value":"922792563","business_name":"AUTUMN LAKE HEALTHCARE AT SILVER SPRING"}}]},
{"provider_group_id":4912437,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1932984143],"tin":{"type":"ein","value":"923173546","business_name":"MONTCARE AT WHEATON"}}]},
{"provider_group_id":4912438,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1952024176],"tin":{"type":"ein","value":"920421686","business_name":"AUTUMN LAKE HEALTHCARE AT BRADDOCK HEIGHTS"}}]},
{"provider_group_id":4912439,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1952047326],"tin":{"type":"ein","value":"881742300","business_name":"AUTUMN LAKE HEALTHCARE AT LONG VIEW"}}]},
{"provider_group_id":4912440,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1962790717],"tin":{"type":"ein","value":"452632600","business_name":"BLUE POINT NURSING LLC"}}]},
{"provider_group_id":4912441,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1972016905],"tin":{"type":"ein","value":"463337720","business_name":"FUTURE CARE CAPITAL REGION"}}]},
{"provider_group_id":4912442,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1972323350],"tin":{"type":"ein","value":"994807599","business_name":"ST ELIZABETH OPCO LLC"}}]},
{"provider_group_id":4912443,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1972785004],"tin":{"type":"ein","value":"260723190","business_name":"FUTURE CARE NORTHPOINT"}}]}
], "in_network" : [
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosag","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91315","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosag","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0172A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"distant site telehealth services","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"G2025","description":"distant site telehealth services","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":108.71,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 25 mcg/0.25 mL dosage, for intramuscular use","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91321","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 25 mcg/0.25 mL dosage, for intramuscular use","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":173.12,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe techniq","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87635","description":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe techniq","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":60.59,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0250","description":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":529.99,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0232","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0232","description":"HCPCS-M0232","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"CPT-90613","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"90613","description":"CPT-90613","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-Q0235","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q0235","description":"HCPCS-Q0235","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent antigen detection by bulk acoustic wave biosensor immunoassay, severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19])","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0408U","description":"Infectious agent antigen detection by bulk acoustic wave biosensor immunoassay, severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19])","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":16.53,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); titer","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86409","description":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); titer","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":93.64,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"U0001","description":"Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0121A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"U0002","description":"2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 3 mcg/0.23 mL dosage, tris-sucrose formulation,","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91318","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 3 mcg/0.23 mL dosage, tris-sucrose formulation,","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":77.12,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0151A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19])","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87426","description":"severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19])","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":41.71,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Antibody testing for a public health related pathogen, including coronavirus.","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D0605","description":"Antibody testing for a public health related pathogen, including coronavirus.","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":57.84,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Injection, remdesivir, 1 mg","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"J0248","description":"Injection, remdesivir, 1 mg","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":8.26,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19])","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86769","description":"Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19])","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":49.58,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approximately 15 minutes","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"99401","description":"Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approximately 15 minutes","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":44.77,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0233","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0233","description":"HCPCS-M0233","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require suppleme","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"Q0249","description":"Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require suppleme","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":9.05,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0223U","description":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) antibody, quantitative","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86413","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) antibody, quantitative","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":60.59,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single step method (eg, reagent strip); severe acute respiratory syndrome coronavirus 2 (SARS-","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86328","description":"Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single step method (eg, reagent strip); severe acute respiratory syndrome coronavirus 2 (SARS-","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":53.51,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-Q0234","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q0234","description":"HCPCS-Q0234","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0142A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 50mcg/0.25mL IM DOSE BOOSTER","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1711","description":"SARSCOV2 COVID-19 VAC mRNA 50mcg/0.25mL IM DOSE BOOSTER","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); screen","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86408","description":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); screen","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":49.58,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"CPT-90481","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"90481","description":"CPT-90481","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disea","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87811","description":"Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disea","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":48.79,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"K1034","description":"Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosa","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91316","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosa","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0202U","description":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0236","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0236","description":"HCPCS-M0236","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0238","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0238","description":"HCPCS-M0238","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosa","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91313","description":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosa","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Molecular testing for a public health related pathogen, including coronavirus","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D0606","description":"Molecular testing for a public health related pathogen, including coronavirus","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":115.28,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; ; respirator","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87633","description":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; ; respirator","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"CPT-91323","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"91323","description":"CPT-91323","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":238.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patients home; reported only once per individual home per date of service when such v","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0201","description":"Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patients home; reported only once per individual home per date of service when such v","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":45.25,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), influenza virus types A","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87637","description":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), influenza virus types A","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":168.01,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-Q0238","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q0238","description":"HCPCS-Q0238","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":6.69,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 3","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1710","description":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 3","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) and influenza virus type","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87636","description":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) and influenza virus type","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":168.01,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0231","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0231","description":"HCPCS-M0231","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; respiratory","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87632","description":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; respiratory","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":256.93,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0234","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0234","description":"HCPCS-M0234","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), includes titer(s), when performed","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0224U","description":"Antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), includes titer(s), when performed","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":60.59,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 1","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1701","description":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 1","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0171A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 2","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1704","description":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 2","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 10 mcg/0.23 mL dosage, tris-sucrose formulation,","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91319","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 10 mcg/0.23 mL dosage, tris-sucrose formulation,","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":111.74,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Immunoassay for infectious agent antibody(ies), qualitative or semi quantitative, single-step method (eg, reagent strip);","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86318","description":"Immunoassay for infectious agent antibody(ies), qualitative or semi quantitative, single-step method (eg, reagent strip);","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":21.25,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation,","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91320","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation,","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":198.31,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-Q0237","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q0237","description":"HCPCS-Q0237","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":5.9,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dos","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91314","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dos","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent genotype analysis by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), mutation identi","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87913","description":"Infectious agent genotype analysis by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), mutation identi","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":303.36,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Publ","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"99072","description":"Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Publ","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 50 mcg/0.5 mL dosage, for intramuscular use","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91322","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 50 mcg/0.5 mL dosage, for intramuscular use","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":190.44,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0237","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0237","description":"HCPCS-M0237","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary’s home that has been made provider","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0248","description":"Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary’s home that has been made provider","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preserva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91304","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preserva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":226.24,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunoch","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87428","description":"Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunoch","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":82.63,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0141A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious disease (bacterial or viral respiratory tract infection) pathogen-specific DNA and RNA, 21 targets, including severe acute respiratory syndrome coronavirus 2 (SARS-","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0225U","description":"Infectious disease (bacterial or viral respiratory tract infection) pathogen-specific DNA and RNA, 21 targets, including severe acute respiratory syndrome coronavirus 2 (SARS-","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"CPT-87812","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"87812","description":"CPT-87812","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":87.74,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syn","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87631","description":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syn","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":168.01,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91317","description":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 1","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1703","description":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 1","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0235","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0235","description":"HCPCS-M0235","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Surrogate viral neutralization test (sVNT), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), ELISA, plasma, serum","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0226U","description":"Surrogate viral neutralization test (sVNT), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), ELISA, plasma, serum","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":49.97,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"CPT-90612","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"90612","description":"CPT-90612","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 3","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1708","description":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 3","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0249","description":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":529.99,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosag","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91312","description":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosag","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0236","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0236","description":"HCPCS-M0236","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe techniq","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87635","description":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe techniq","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":60.59,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), includes titer(s), when performed","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0224U","description":"Antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), includes titer(s), when performed","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":60.59,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) (coronavirus disease [COVID-19]) vaccine, single dose","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"90480","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) (coronavirus disease [COVID-19]) vaccine, single dose","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":26.9,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Surrogate viral neutralization test (sVNT), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), ELISA, plasma, serum","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0226U","description":"Surrogate viral neutralization test (sVNT), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), ELISA, plasma, serum","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":49.97,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"distant site telehealth services","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"G2025","description":"distant site telehealth services","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":108.71,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91317","description":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; respiratory","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87632","description":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; respiratory","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":256.93,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); titer","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86409","description":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); titer","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":93.64,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosag","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91312","description":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosag","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 1","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1703","description":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 1","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"K1034","description":"Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"CPT-90612","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"90612","description":"CPT-90612","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-Q0234","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q0234","description":"HCPCS-Q0234","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0121A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 3","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1710","description":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 3","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Molecular testing for a public health related pathogen, including coronavirus","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D0606","description":"Molecular testing for a public health related pathogen, including coronavirus","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":115.28,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-Q0235","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q0235","description":"HCPCS-Q0235","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 3 mcg/0.23 mL dosage, tris-sucrose formulation,","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91318","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 3 mcg/0.23 mL dosage, tris-sucrose formulation,","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":77.12,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single step method (eg, reagent strip); severe acute respiratory syndrome coronavirus 2 (SARS-","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86328","description":"Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single step method (eg, reagent strip); severe acute respiratory syndrome coronavirus 2 (SARS-","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":53.51,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosa","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91313","description":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosa","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Injection, remdesivir, 1 mg","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"J0248","description":"Injection, remdesivir, 1 mg","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":8.26,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent genotype analysis by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), mutation identi","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87913","description":"Infectious agent genotype analysis by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), mutation identi","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":303.36,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"CPT-90481","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"90481","description":"CPT-90481","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preserva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91304","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preserva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":226.24,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syn","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87631","description":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syn","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":168.01,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent antigen detection by bulk acoustic wave biosensor immunoassay, severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19])","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0408U","description":"Infectious agent antigen detection by bulk acoustic wave biosensor immunoassay, severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19])","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":16.53,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0223U","description":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0231","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0231","description":"HCPCS-M0231","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0237","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0237","description":"HCPCS-M0237","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) (coronavirus disease [COVID-19]) vaccine, single dose","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"90480","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) (coronavirus disease [COVID-19]) vaccine, single dose","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":26.9,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-Q0238","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q0238","description":"HCPCS-Q0238","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":6.69,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 1","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1701","description":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 1","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0234","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0234","description":"HCPCS-M0234","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0232","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0232","description":"HCPCS-M0232","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"U0001","description":"Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 2","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1704","description":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 2","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19])","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86769","description":"Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19])","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":49.58,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Antibody testing for a public health related pathogen, including coronavirus.","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D0605","description":"Antibody testing for a public health related pathogen, including coronavirus.","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":57.84,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0238","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0238","description":"HCPCS-M0238","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 10 mcg/0.23 mL dosage, tris-sucrose formulation,","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91319","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 10 mcg/0.23 mL dosage, tris-sucrose formulation,","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":111.74,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosa","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91316","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosa","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation,","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91320","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation,","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":198.31,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) antibody, quantitative","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86413","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) antibody, quantitative","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":60.59,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunoch","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87428","description":"Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunoch","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":82.63,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0142A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) and influenza virus type","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87636","description":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) and influenza virus type","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":168.01,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dos","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91314","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dos","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0202U","description":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-Q0237","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q0237","description":"HCPCS-Q0237","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":5.9,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"CPT-87812","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"87812","description":"CPT-87812","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":87.74,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require suppleme","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"Q0249","description":"Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require suppleme","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":9.05,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0171A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19])","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87426","description":"severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19])","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":41.71,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"CPT-91323","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"91323","description":"CPT-91323","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":238.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 50mcg/0.25mL IM DOSE BOOSTER","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1711","description":"SARSCOV2 COVID-19 VAC mRNA 50mcg/0.25mL IM DOSE BOOSTER","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious disease (bacterial or viral respiratory tract infection) pathogen-specific DNA and RNA, 21 targets, including severe acute respiratory syndrome coronavirus 2 (SARS-","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0225U","description":"Infectious disease (bacterial or viral respiratory tract infection) pathogen-specific DNA and RNA, 21 targets, including severe acute respiratory syndrome coronavirus 2 (SARS-","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patients home; reported only once per individual home per date of service when such v","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0201","description":"Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patients home; reported only once per individual home per date of service when such v","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":45.25,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approximately 15 minutes","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"99401","description":"Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approximately 15 minutes","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":44.77,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0151A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), influenza virus types A","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87637","description":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), influenza virus types A","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":168.01,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"CPT-90613","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"90613","description":"CPT-90613","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"U0002","description":"2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0235","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0235","description":"HCPCS-M0235","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0233","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0233","description":"HCPCS-M0233","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); screen","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86408","description":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); screen","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":49.58,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0249","description":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":529.99,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosag","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91315","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosag","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; ; respirator","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87633","description":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; ; respirator","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 50 mcg/0.5 mL dosage, for intramuscular use","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91322","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 50 mcg/0.5 mL dosage, for intramuscular use","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":190.44,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Publ","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"99072","description":"Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Publ","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Immunoassay for infectious agent antibody(ies), qualitative or semi quantitative, single-step method (eg, reagent strip);","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86318","description":"Immunoassay for infectious agent antibody(ies), qualitative or semi quantitative, single-step method (eg, reagent strip);","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":21.25,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0250","description":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":529.99,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 3","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1708","description":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 3","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0141A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary’s home that has been made provider","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0248","description":"Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary’s home that has been made provider","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disea","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87811","description":"Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disea","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":48.79,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0172A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 25 mcg/0.25 mL dosage, for intramuscular use","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91321","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 25 mcg/0.25 mL dosage, for intramuscular use","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":173.12,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[4912316]}]}]}